Research hold: do not translate human longevity content into a canine dose or lifespan claim.
The atlas separates a biological hypothesis, a canine or feline measurement, a controlled clinical result and a commercial longevity claim. They are not interchangeable.
What was actually measured?
Research hold
No claim has passed the internal evidence contract for this record. The page remains noindex.
No human-to-pet conversion.
Policy
Dose content is blocked pending full primary-study extraction, safety assessment and named veterinary review.
“Pet supplement” is not a universal legal category.
FDA does not recognise a separate dietary-supplement category for animal products; depending on intended use, products are regulated as animal food or animal drugs. Disease-treatment or prevention claims can indicate new-animal-drug intent.
Open FDA source →Trace every material statement.
Exploring the therapeutic potential of β-nicotinamide mononucleotide in regulating canine NT-proBNP levels2026 canine biomarker study awaiting full internal appraisal · 2026Open source →
Subacute Toxicity Study of Nicotinamide Mononucleotide via Oral Administrationtoxicity study including dogs; not a longevity efficacy study · 2020Open source →
Page data version: 2026-08-18. Medical review is not claimed without a named sign-off.